The Future Of US Funding For HIV Treatment And Prevention
1A
00:00
HIV Research: Funding Challenges and Advancements
This chapter explores the transformative impact of a multi-site consortium in HIV research, linking its findings to advancements in COVID treatments and autoimmune therapies. It highlights the critical funding challenges researchers face, particularly concerning ongoing clinical trials and the potential dangers of cutting support for HIV initiatives. Additionally, the chapter discusses the rollout of a promising long-acting prevention tool, Lenacapavir, while emphasizing the urgency of maintaining access to essential medications and fostering public-private partnerships in global health.
Transcript
Play full episode
